Encouraging Efficacy Observed in Bexmab Study: A Phase 1/2 Study to Assess Safety and Efficacy of Bexmarilimab in Combination with Standard of Care in Myeloid Malignancies
Mika Kontro,Anthony S. Stein,Marja Pyörälä,Johanna Rimpiläinen,Timo Siitonen,Maija Hollmén,Marie-Louise Fjaellskog,Inka Pawlitzky,Amer M. Zeidan,Naval Daver
出处
期刊:Blood [American Society of Hematology] 日期:2023-11-02卷期号:142 (Supplement 1): 2915-2915被引量:2